Many MedTech manufacturers, particularly those with Class I devices, often underestimate the regulatory hurdles in the MENA region. This episode tackles a frequently asked and critically important question: Is a local Authorized Representative really necessary for a low-risk Class I medical device in Saudi Arabia? The answer might surprise you and could be the difference between successful market entry and costly delays. We break down the specific requirements set by the Saudi Food and Drug Authority (SFDA). We move beyond a simple 'yes' or 'no' to explain the strategic importance of this role, the responsibilities it entails, and how it impacts your entire commercial strategy in the Kingdom. Learn from the cautionary tale of a European gown manufacturer whose first shipment was blocked at customs for months, all due to one common misunderstanding about local representation. In This Episode: * Why does the SFDA require an Authorized Representative for all device classes, including Class I? * Can any local distributor act as your legal Authorized Representative in Saudi Arabia? * What are the specific legal responsibilities an AR holds for a low-risk device? * How can tying your device registration to a distributor limit your future business flexibility? * What is the single most common mistake foreign manufacturers make when entering the Saudi market? * How does the AR manage post-market surveillance and reporting for Class I devices? * What is the SFDA's GHAD system and why is your AR's role in it so critical? Navigating the complexities of global MedTech regulations is what we do best. At Pure Global, we offer end-to-end regulatory consulting, acting as your local representative in over 30 markets, including Saudi Arabia. Our blend of local expertise and advanced AI tools streamlines your path to market access. Don't let regulatory hurdles slow your growth. Contact us for a consultation at [email protected] or visit our website at https://pureglobal.com/.